BridgeBio Pharma, Inc. (BBIO) Dividend Yield, History & Forecast
BridgeBio Pharma, Inc. (BBIO) is a Biotechnology company in the Healthcare sector listed on the NASDAQ Global Select. market capitalization is approximately $14.18B.
Frequently Asked Questions about BridgeBio Pharma, Inc. (BBIO)
Is BridgeBio Pharma, Inc. a Dividend Aristocrat?▾
Dividend Aristocrat status requires an S&P 500 listing and 25 or more consecutive years of dividend increases. See our curated Dividend Aristocrats list for the full roster.
What sector is BridgeBio Pharma, Inc. in?▾
BridgeBio Pharma, Inc. (BBIO) operates in the Healthcare sector, specifically the Biotechnology industry.
